alpha-(4-fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazine butanol has been researched along with neurotensin in 3 studies
| Studies (alpha-(4-fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazine butanol) | Trials (alpha-(4-fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazine butanol) | Recent Studies (post-2010) (alpha-(4-fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazine butanol) | Studies (neurotensin) | Trials (neurotensin) | Recent Studies (post-2010) (neurotensin) |
|---|---|---|---|---|---|
| 90 | 1 | 2 | 4,054 | 45 | 544 |
| Protein | Taxonomy | alpha-(4-fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazine butanol (IC50) | neurotensin (IC50) |
|---|---|---|---|
| Neurotensin receptor type 1 | Homo sapiens (human) | 0.0013 | |
| Neurotensin receptor type 2 | Rattus norvegicus (Norway rat) | 0.0582 | |
| Sortilin | Homo sapiens (human) | 0.36 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dorsa, DM; Levant, B; Merchant, KM; Nemeroff, CB | 1 |
| Levant, B; Nemeroff, CB | 2 |
3 other study(ies) available for alpha-(4-fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazine butanol and neurotensin
| Article | Year |
|---|---|
BMY 14802, a potential antipsychotic drug, increases expression of proneurotensin mRNA in the rat striatum.
Topics: Amino Acid Sequence; Analysis of Variance; Animals; Antipsychotic Agents; Base Sequence; Brain; Corpus Striatum; Gene Expression; Immune Sera; Male; Molecular Sequence Data; Neurotensin; Oligonucleotide Probes; Oligopeptides; Organ Specificity; Protein Precursors; Pyrimidines; Radioimmunoassay; Rats; Rats, Inbred Strains; Receptors, Opioid; Receptors, Opioid, mu; RNA, Messenger | 1992 |
Further studies on the modulation of regional brain neurotensin concentrations by antipsychotic drugs: focus on haloperidol and BMY 14802.
Topics: Animals; Benzazepines; Brain; Drug Interactions; Haloperidol; Injections, Intraperitoneal; Male; Neurotensin; Psychotropic Drugs; Pyrimidines; Rats; Rats, Inbred Strains; Sulpiride | 1992 |
Sigma receptor "antagonist" BMY 14802 increases neurotensin concentrations in the rat nucleus accumbens and caudate.
Topics: Animals; Anti-Anxiety Agents; Caudate Nucleus; Male; Neurotensin; Nucleus Accumbens; Pyrimidines; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D2; Receptors, N-Methyl-D-Aspartate; Receptors, Neurotransmitter; Receptors, Opioid; Receptors, sigma; Septal Nuclei | 1990 |